Use of oral glycopyrronium bromide in hyperhidrosis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 17459043.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Idiopathic hyperhidrosis may be a disabling condition causing emotional stress and negative impact on a patient's quality of life. Oral anticholinergics are one of the treatments available. There are few published data on the use of the anticholinergic drug glycopyrronium bromide (glycopyrrolate) given orally in the treatment of hyperhidrosis. To report a retrospective analysis describing the treatment responses, doses and side-effects of oral glycopyrrolate in the treatment of idiopathic hyperhidrosis. Review of case notes in a series of 24 patients, nine with generalized and 15 with localized hyperhidrosis. Fifteen of 19 evaluable patients (79%) responded to oral glycopyrrolate. However, treatment was limited by side-effects in around one third of patients. A prospective clinical study to compare the efficacy and side-effects of oral anticholinergics is warranted.
Medical subject headings
- Cholinergic Antagonists
- Glycopyrrolate
- Hyperhidrosis
- Muscarinic Antagonists